BeStock  

Regencell Bioscience RGC

US equityMarket cap rank #2658Drug Manufacturers - Specialty & Generic
$4.18 −$0.18 (-4.13%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.18 0.00%
Open$4.43
Prev close$4.36
Day range$4.12 – $4.43
Volume111.1K
Market cap$2.07B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-205.8x
CheapRich

Around its usual level · 41st percentile, 5-year average -682.8x

Price / book183.0x
CheapRich

Above its usual level · 69th percentile, 5-year average 790.0x

#5310 of 5330 stocks by PB (1 = cheapest)

P/E over five years

-7,108x-4,369x-1,629x1,110xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$5.47
Price vs. fair value-23.5%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 182.96 – 790.04 69% (pricier than usual) #5310 of 5330 (1 = cheapest)
PE -205.83 – -682.80 41% (cheaper than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on RGC.

Sign in to join the discussion.

Scroll to Top